Amazon Bio Discovery developed three AI approaches to accelerate antibody drug design: MochiBind (sequence-based affinity ranking), CA-MAP (developability prediction with batch effect correction), and an agent-guided design system with 46 lab-validated hits against a novel cancer
The latest news and research from Amazon's science community. #AmazonScience


